| Interleukin-2 and regulatory T cells in graft-versus-host disease J Koreth, K Matsuoka, HT Kim, SM McDonough, B Bindra, EP Alyea III, ... New England Journal of Medicine 365 (22), 2055-2066, 2011 | 1241 | 2011 |
| IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo E Zorn, EA Nelson, M Mohseni, F Porcheray, H Kim, D Litsa, R Bellucci, ... Blood 108 (5), 1571-1579, 2006 | 925 | 2006 |
| Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation P Armand, HT Kim, BR Logan, Z Wang, EP Alyea, ME Kalaycio, ... Blood, The Journal of the American Society of Hematology 123 (23), 3664-3671, 2014 | 854 | 2014 |
| Ipilimumab for patients with relapse after allogeneic transplantation MS Davids, HT Kim, P Bachireddy, C Costello, R Liguori, A Savell, ... New England Journal of Medicine 375 (2), 143-153, 2016 | 577 | 2016 |
| Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease E Zorn, HT Kim, SJ Lee, BH Floyd, D Litsa, S Arumugarajah, R Bellucci, ... Blood 106 (8), 2903-2911, 2005 | 570 | 2005 |
| Cumulative incidence in competing risks data and competing risks regression analysis HT Kim Clinical cancer research 13 (2), 559-565, 2007 | 560 | 2007 |
| Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation P Armand, HT Kim, CS Cutler, VT Ho, J Koreth, EP Alyea, RJ Soiffer, ... Blood 109 (10), 4586-4588, 2007 | 541 | 2007 |
| Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease K Matsuoka, J Koreth, HT Kim, G Bascug, S McDonough, Y Kawano, ... Science translational medicine 5 (179), 179ra43-179ra43, 2013 | 521 | 2013 |
| Rituximab for steroid-refractory chronic graft-versus-host disease C Cutler, D Miklos, HT Kim, N Treister, SB Woo, D Bienfang, LB Klickstein, ... Blood 108 (2), 756-762, 2006 | 513 | 2006 |
| Antibody responses to HY minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission DB Miklos, HT Kim, KH Miller, L Guo, E Zorn, SJ Lee, EP Hochberg, ... Blood 105 (7), 2973-2978, 2005 | 492 | 2005 |
| A disease risk index for patients undergoing allogeneic stem cell transplantation P Armand, CJ Gibson, C Cutler, VT Ho, J Koreth, EP Alyea, J Ritz, ... Blood, The Journal of the American Society of Hematology 120 (4), 905-913, 2012 | 395 | 2012 |
| Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age EP Alyea, HT Kim, V Ho, C Cutler, J Gribben, DJ DeAngelo, SJ Lee, ... Blood 105 (4), 1810-1814, 2005 | 376 | 2005 |
| Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease S Sarantopoulos, KE Stevenson, HT Kim, CS Cutler, NS Bhuiya, ... Blood, The Journal of the American Society of Hematology 113 (16), 3865-3874, 2009 | 371 | 2009 |
| Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation C Cutler, P Multani, D Robbins, HT Kim, T Le, J Hoggatt, LM Pelus, ... Blood, The Journal of the American Society of Hematology 122 (17), 3074-3081, 2013 | 350 | 2013 |
| Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity BL Lampson, SN Kasar, TR Matos, EA Morgan, L Rassenti, MS Davids, ... Blood, The Journal of the American Society of Hematology 128 (2), 195-203, 2016 | 325 | 2016 |
| The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations FR Appelbaum, KJ Kopecky, MS Tallman, ML Slovak, HM Gundacker, ... British journal of haematology 135 (2), 165-173, 2006 | 314 | 2006 |
| High levels of B-cell activating factor in patients with active chronic graft-versus-host disease S Sarantopoulos, KE Stevenson, HT Kim, NS Bhuiya, CS Cutler, ... Clinical Cancer Research 13 (20), 6107-6114, 2007 | 308 | 2007 |
| Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation K Matsuoka, HT Kim, S McDonough, G Bascug, B Warshauer, J Koreth, ... The Journal of clinical investigation 120 (5), 1479-1493, 2010 | 289 | 2010 |
| Prospective, randomized, double-blind, phase III clinical trial of anti–T-lymphocyte globulin to assess impact on chronic graft-versus-host disease–free survival in patients … RJ Soiffer, HT Kim, J McGuirk, ME Horwitz, L Johnston, MM Patnaik, ... Journal of Clinical Oncology 35 (36), 4003, 2017 | 283 | 2017 |
| Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution S Kasar, J Kim, R Improgo, G Tiao, P Polak, N Haradhvala, MS Lawrence, ... Nature communications 6 (1), 8866, 2015 | 276 | 2015 |
